Investment Summary |
|
|---|---|
| Date | 2019-12-23 |
| Target | SmartPush |
| Sector | Information Technology |
| Investor(s) | Truffle Capital |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 700M EUR |
| Size | Middle-Market |
| Type | Sector Focused |
Truffle Capital is a French private equity firm focused on majority investments in life science and information technology companies. Within IT, Truffle seeks businesses dealing in mobile content and connectivity, internet, technical software, IT security, and VOIP. Within the life science sector, the Firm looks at opportunities in therapeutic drugs and vaccines, medical devices, as well as other breakthrough technologies. Truffle Capital was formed in 2001 and is based in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 44 of 45 |
| Sector: Information Technology M&A | 4 of 4 |
| Type: Stake Purchase M&A Deals | 4 of 4 |
| Country: France M&A | 32 of 33 |
| Year: 2019 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-01 |
BariaTek
Paris, France BariaTek is dedicated to the development of innovative medical devices intended to combat obesity and diabetes, two pandemics affecting more than a billion patients around the world. These minimally invasive devices are implanted in a few minutes by endoscopy and reproduce the effects of obesity surgery (or bariatric surgery). BariaTek is based in Paris, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-01 |
Caranx Medical
Paris, France Caranx Medical's mission is to design and develop new intelligent and autonomous surgical robots, combining artificial intelligence and intervention guided by robotic assistance, to help surgeons and improve patient outcomes. The first targeted applications are the replacement of aortic valves (TAVI) and the endoscopic treatment of obesity. Caranx Medical was founded in 2020 and is based in Paris, France. |
Buy | - |
